FolioLanternBeta
ETONEton Pharmaceuticals, Inc.

Paul Maier

Director at Eton Pharmaceuticals, Inc., as of Aug 31, 2026Sold $3.0M of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
50K
shares sold, past 12 months
1
days with sales
$3.0M
largest single day, Aug 28, 2026
2
companies filed for

Share of stake sold and shares held at Eton Pharmaceuticals, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAug 2026: $3.0M no plan disclosed$3.0MAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Eton Pharmaceuticals, Inc. (ETON)DirectorNov 13, 2018Aug 31, 2026
Ligand Pharmaceuticals Inc (LGND)Former Sr. V-P, CFONov 21, 2003Nov 22, 2006

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.